Boer Daniel Anton De
Chief Executive Officer at ProQR Therapeutics N.V.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 7 months
- Director since
- 2026
7 months of board service in total across 1 board, counting each seat separately. Longest: ProQR Therapeutics N.V., 7 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | ProQR Therapeutics N.V. | Open-market purchase | +200,000 | $1.77 | $354,000 |
| Jul 9, 2026 | ProQR Therapeutics N.V. | Open-market purchase | +150,000 | $1.74 | $261,000 |
| Jul 7, 2026 | ProQR Therapeutics N.V. | Open-market purchase | +150,000 | $1.59 | $238,500 |
Questions about Boer Daniel Anton De
What boards is Boer Daniel Anton De on?
Boer Daniel Anton De sits on the board of ProQR Therapeutics N.V.
What company is Boer Daniel Anton De the CEO of?
Boer Daniel Anton De has been Chief Executive Officer of ProQR Therapeutics N.V. since March 2026.
How long has Boer Daniel Anton De served on boards?
Our records show at least 7 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.